LEAP is how we unlock the brightest future possible for people with Kabuki syndrome. We identified our community’s greatest needs, analyzed gaps in current research, then created a plan that addresses those gaps and enables treatment development for people with Kabuki syndrome around the world.
We’ve secured and designated over $2,000,000 to support LEAP. Every dollar counts as we aim to raise $3,500,000 over the next two years.
LEAP is an evolving roadmap to treatments for Kabuki syndrome. These goals reflect our Phase 1, June 2023 – December 2025 strategy and progress.